Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1 Interventional

Open Label, Dose-finding, Pharmacokinetics, Safety and Tolerability Study of Oritavancin in Pediatric Participants With Suspected or Confirmed Bacterial Infections

ClinicalTrials.gov ID: NCT02134301

Public ClinicalTrials.gov record NCT02134301. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 24, 2026, 6:32 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open Label, Dose-finding, Pharmacokinetics, Safety, and Tolerability Study of Oritavancin Single Dose Infusion in Pediatric Subjects Less Than 18 Years of Age With Suspected or Confirmed Bacterial Infections

Study identification

NCT ID
NCT02134301
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1
Lead sponsor
Melinta Therapeutics, LLC
Industry
Enrollment
41 participants

Conditions and interventions

Interventions

  • Oritavancin Drug

Drug

Eligibility (public fields only)

Age range
Up to 18 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 2014
Primary completion
Nov 3, 2025
Completion
Nov 3, 2025
Last update posted
Dec 11, 2025

2014 – 2025

United States locations

U.S. sites
8
U.S. states
5
U.S. cities
8
Facility City State ZIP Site status
Arkansas Children's Hospital Little Rock Arkansas 72202
Children's Hospital of Orange County Orange California 92868
Rady Children's Hospital San Diego California 92123
UCLA Harbor Medical Center Torrance California 90502
Univ of Louisville, Norton Children's Research Institute Louisville Kentucky 40202
University of Nebraska Medical Center Omaha Nebraska 68114
Rainbow Babies and Children's Hospital Cleveland Ohio 44106
Toledo Children's Hospital Toledo Ohio 43606

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02134301, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 11, 2025 · Synced Jul 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02134301 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →